Dr. Anil Chandraker is a graduate of Glasgow University Medical School and trained in clinical medicine in the United Kingdom before coming to the Brigham and Women’s Hospital/Harvard Medical School to pursue a Fellowship in Nephrology/Transplant Immunology. Dr. Chandraker is the Medical Director of Kidney and Pancreas Transplantation and the Interim Director of the Transplantation Research Center at the Brigham and Women’s Hospital. He is an Associate Professor Medicine at Harvard Medical School and serves as the Secretary of the American Society of Transplantation.
Dr. Chandraker has academic interests in basic, translational and clinical areas of transplantation research. He serves as the overall PI on an NIH sponsored Clinical Trials in Organ Transplantation Consortium examining the development and role of anti HLA antibodies in kidney and heart transplantation. In addition he has clinical/translational research interests in BK nephropathy, anemia and genetics of transplantation. His basic research interest is focused primarily on T cell costimulatory pathways such as the B7-CD28/CTLA4 and PDL1-PD1 pathways and their role in tolerance and chronic allograft injury. He has mentored eighteen fellows in basic and clinical research and received research funding from the NIH, Juvenile Diabetes Research Foundation and the National Kidney Foundation. He has co-authored over a 120 original scientific articles, review articles and book chapters including contributing chapters to Harrisons, Brenner and Rectors The Kidney, AST Primer on Transplantation and ACP Medicine Textbook.